Descriptive Analysis of Real-World Data on Fingolimod Long-Term Treatment of Young Adult RRMS Patients

por Ziemssen, Tjalf, Albrecht, Holger, Haas, Judith, Klotz, Luisa, Lang, Michael, Lassek, Christoph, Schmidt, Stephan, Ettle, Benjamin, Schulze-Topphoff, Ulf
Publicado 2021

Clinical and Demographic Profile of Patients Receiving Fingolimod in Clinical Practice in Germany and the Benefit–Risk Profile of Fingolimod After 1 Year of Treatment: Initial Resu...

por Ziemssen, Tjalf, Lang, Michael, Tackenberg, Björn, Schmidt, Stephan, Albrecht, Holger, Klotz, Luisa, Haas, Judith, Lassek, Christoph, Medin, Jennie, Cornelissen, Christian
Publicado 2017

Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany

por Ziemssen, Tjalf, Lang, Michael, Schmidt, Stephan, Albrecht, Holger, Klotz, Luisa, Haas, Judith, Lassek, Christoph, Lang, Stefan, Winkelmann, Veronika E., Ettle, Benjamin, Schulze-Topphoff, Ulf
Publicado 2022

Real-world persistence and benefit–risk profile of fingolimod over 36 months in Germany

por Ziemssen, Tjalf, Lang, Michael, Tackenberg, Björn, Schmidt, Stephan, Albrecht, Holger, Klotz, Luisa, Haas, Judith, Lassek, Christoph, Couto, C. Anne-Marie, Findlay, John A., Cornelissen, Christian
Publicado 2019